|Day Low/High||3.14 / 3.25|
|52 Wk Low/High||2.93 / 4.89|
Availability of full suite of Xoft System products in China represents significant milestone in expanding global access to advanced technology to treat range of cancers
Conference Call today at 4:30 p.m. ET
Preliminary results show targeted approach reduces toxicity to organs at risk
Results of breakthrough study published in peer-reviewed Journal of Contemporary Brachytherapy showed no statistically significant difference in recurrence of cancer at mean follow-up of 3.4 years
iCAD's revolutionary PowerLook® Tomo Detection deep learning solution helps radiologists identify breast cancer more efficiently
Preliminary results show targeted treatment offers low toxicity for patients with endometrial or cervical cancer
First installation of advanced, multi-platform Xoft System in Australia increases global access to versatile, clinically proven technology
This portfolio is designed to produce a blended yield of 6% to 8%.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.